Literature DB >> 20215596

Parkinson's disease and cancer: the unexplored connection.

Ken Garber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215596     DOI: 10.1093/jnci/djq081

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  12 in total

1.  Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.

Authors:  Ilir Agalliu; Marta San Luciano; Anat Mirelman; Nir Giladi; Bjorg Waro; Jan Aasly; Rivka Inzelberg; Sharon Hassin-Baer; Eitan Friedman; Javier Ruiz-Martinez; Jose Felix Marti-Masso; Avi Orr-Urtreger; Susan Bressman; Rachel Saunders-Pullman
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

Review 2.  Pathologic and therapeutic implications for the cell biology of parkin.

Authors:  Rakshita A Charan; Matthew J LaVoie
Journal:  Mol Cell Neurosci       Date:  2015-02-17       Impact factor: 4.314

3.  Functional variants in DCAF4 associated with lung cancer risk in European populations.

Authors:  Hongliang Liu; Zhensheng Liu; Yanru Wang; Thomas E Stinchcombe; Kouros Owzar; Younghun Han; Rayjean J Hung; Yonathan Brhane; John McLaughlin; Paul Brennan; Heike Bickeböller; Albert Rosenberger; Richard S Houlston; Neil Caporaso; Maria T Landi; Irene Brüske; Angela Risch; Xifeng Wu; Yuanqing Ye; David C Christiani; Christopher I Amos; Qingyi Wei
Journal:  Carcinogenesis       Date:  2017-05-01       Impact factor: 4.944

4.  Lack of association between cancer history and PARKIN genotype: a family based study in PARKIN/Parkinson's families.

Authors:  Roy N Alcalay; Lorraine N Clark; Karen S Marder; W Edward C Bradley
Journal:  Genes Chromosomes Cancer       Date:  2012-08-24       Impact factor: 5.006

5.  α-Synuclein expression selectively affects tumorigenesis in mice modeling Parkinson's disease.

Authors:  Eitan Israeli; Eugenia Yakunin; Yonaton Zarbiv; Amir Hacohen-Solovich; Haya Kisos; Virginie Loeb; Michal Lichtenstein; Tziona Ben-Gedalya; Ofra Sabag; Eli Pikarsky; Haya Lorberboum-Galski; Ronit Sharon
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

Review 6.  Cancer and neurodegeneration: between the devil and the deep blue sea.

Authors:  Hélène Plun-Favreau; Patrick A Lewis; John Hardy; L Miguel Martins; Nicholas W Wood
Journal:  PLoS Genet       Date:  2010-12-23       Impact factor: 5.917

Review 7.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update.

Authors:  Da-Zhi Liu; Bradley P Ander
Journal:  ScientificWorldJournal       Date:  2012-04-01

8.  A systems biology approach to identify intelligence quotient score-related genomic regions, and pathways relevant to potential therapeutic treatments.

Authors:  Min Zhao; Lei Kong; Hong Qu
Journal:  Sci Rep       Date:  2014-02-25       Impact factor: 4.379

9.  Neurodegeneration and Cancer: Where the Disorder Prevails.

Authors:  Petr Klus; Davide Cirillo; Teresa Botta Orfila; Gian Gaetano Tartaglia
Journal:  Sci Rep       Date:  2015-10-23       Impact factor: 4.379

10.  Co-morbidities of persons dying of Parkinson's disease.

Authors:  Lynn Lethbridge; Grace M Johnston; George Turnbull
Journal:  Prog Palliat Care       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.